Efficacy, Safety, and Pharmacokinetics of a New 10 % Liquid Intravenous Immunoglobulin Containing High Titer Neutralizing Antibody to RSV and Other Respiratory Viruses in Subjects with Primary Immunodeficiency Disease

PURPOSE: Immune globulins for IgG supplementation have been produced for over 35 years with essentially no differentiating features regarding their specific antibody composition. Furthermore, the compositions of plasma donor pools used for IG manufacturing are not standardized. While all immune glob...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Clin Immunol
Main Authors: Wasserman, Richard L., Lumry, William, Harris, James, Levy, Robyn, Stein, Mark, Forbes, Lisa, Cunningham-Rundles, Charlotte, Melamed, Isaac, Kobayashi, Ai Lan, Du, Wei, Kobayashi, Roger
Format: Artigo
Jezik:Inglês
Izdano: Springer US 2016
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4940435/
https://ncbi.nlm.nih.gov/pubmed/27324887
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10875-016-0308-z
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki